FEMY completed significant equity financing that substantially improved its balance sheet position while reducing current liabilities and expanding inventory investment.
The company's outstanding shares more than doubled from 27.1M to 60.4M shares, indicating a major equity raise that provided capital to fund operations and product development. The substantial reduction in current liabilities from $8.6M to $3.6M suggests the company addressed near-term financial pressures, while the meaningful inventory build indicates preparation for increased commercial activity.
FEMY's financial position improved markedly through what appears to be a substantial equity financing, with total assets growing from $12.4M to $20.7M while current liabilities fell meaningfully. Revenue grew modestly to $2.3M, and the company invested in expanding inventory levels to $5.7M. The dilutive equity raise appears to have provided the capital needed to strengthen the balance sheet and support the company's transition from development to commercialization phase.
Inventory surged 88.4% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.
Buyback activity reduced 73.6% — capital being redeployed elsewhere or cash conservation underway.
Asset base grew 66.5% — expansion through organic growth, acquisitions, or capital deployment.
Current liabilities reduced — improved short-term financial position and working capital health.
Liabilities grew 46.5% — significant increase in debt or obligations, assess impact on financial flexibility.
Strong top-line growth of 40.8% — accelerating demand or successful expansion into new markets.
Capex reduced 31.1% — investment cycle winding down or capital discipline; may improve near-term free cash flow.
Receivables grew 26.3% — monitor days sales outstanding for collection efficiency.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →